Trump signs order to speed review of psychedelics, including controversial drug ibogaine

AP Associated PressSouth China Morning PostFiled 2026-04-18 · 14:41 GMTLean · Center-RightRead · 1 min

Reading time

1_min

Word count

144_words

Sources cited

1_cited

Entities identified

4_entities

Quality score

100_%

§ 01

Briefing Summary

AI-generated

NEWSAR · AI

President Trump signed an executive order directing his administration to expedite the review process for certain psychedelic drugs, including ibogaine. Ibogaine, currently classified as a high-risk, illegal drug by the federal government, has gained recent attention for its potential benefits for combat veterans. The order aims to accelerate access to research and treatments involving these drugs, some of which have already been designated as potential breakthroughs by regulators. Trump stated the directive could offer relief to individuals suffering from debilitating symptoms and potentially improve their lives. The goal is to assess the potential benefits of these drugs and their impact on treatment options.

Confidence 0.85Sources 1Claims 5Entities 4

§ 02

Article analysis

Model · rule-based

Framing

Public Health

Political Strategy

Tone

Measured

AI-assessed

CalmNeutralAlarmist

Factuality

0.70 / 1.00

Factual

LowHigh

Sources cited

Limited

FewMany

§ 03

Key claims

5 extracted

Ibogaine is banned under the federal government’s most restrictive category for illegal, high-risk drugs.

factualArticle

Confidence

1.00

Donald Trump directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine.

factualArticle

Confidence

1.00

His directive will help “dramatically accelerate” access to research and treatments on psychedelic drugs.

quoteTrump

Confidence

0.90

Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life.

quoteTrump

Confidence

0.90

If these turn out to be as good as people are saying, it’s going to have a tremendous impact.

predictionTrump

Confidence

0.70

§ 04

Full report

1 min read · 144 words

US President Donald Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including Ibogaine, which recently has been embraced by combat veterans and conservative lawmakers despite having serious safety risks.Ibogaine is banned under the federal government’s most restrictive category for illegal, high-risk drugs. But the administration is taking steps to ease access to psychedelics that Trump said were already designated as potential breakthroughs by federal regulators.“Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life,” Trump said as he signed an executive order on the drugs. The Republican president said his directive will help “dramatically accelerate” access to research and treatments on psychedelic drugs. “If these turn out to be as good as people are saying, it’s going to have a tremendous impact,” he said.

§ 05